TGY2IT
GILD icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Gilead Sciences GILD Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,840
Closed -$256K – 270
2026
Q1 		$256K Buy
+1,840
New +$258K 0.11% 116

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's GILD Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,840 shares — an estimated $256K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $256K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 1,840 Gilead Sciences shares in Q2 2026, an estimated $256K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Gilead Sciences position peaked at $256K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.